Plunkett Research Online: Ligand Pharmaceuticals Inc

LIGAND PHARMACEUTICALS INC (LGND:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ligand Pharmaceuticals, Inc. develops drugs to address a variety of medical needs in areas including thrombocytopenia, anemia, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. The company currently has a portfolio of over 160 fully-funded partner programs that are all in st.....



Ligand Pharmaceuticals Inc
Ticker: LGND
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 550-7500
Fax: 850 550-1826
Address: 3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diversified
Small-Molecule Drugs
ContactsDescription
John HigginsCEO/Director
Matthew KorenbergCFO/Executive VP, Divisional
See More
Ligand Pharmaceuticals, Inc. develops drugs to address a variety of medical needs in areas including thrombocytopenia, anemia, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. The company currently has a portfolio of over 160 fully-funded partner programs that are all in st.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Promacta
Kyprolis
Captisol
Viviant
Conbriza
Revolade
sparsentan
Sage-547
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: